From Adalimumab to orally administered secretory IgA: preclinical characterization of ABC-301

Reformatting therapeutic immunoglobulin G (IgG) antibodies into secretory immunoglobulin A (sIgA) may provide an alternative architecture for mucosal drug delivery. We characterized ABC-301, a recombinant human sIgA1 incorporating the antigen-binding regions of Adalimumab, and evaluated its human tumor necrosis factor alpha (TNFα) neutralization, oral activity in experimental colitis, tissue biodistribution, and susceptibility to patient-derived anti-Adalimumab antibodies. ABC-301 retained human TNFα binding and functional neutralization in vitro. Its whole-molecule molar neutralization IC50 was approximately 3.3-fold lower than that of Adalimumab, a difference of approximately 1.6-fold after normalization to theoretical binding-site number. In dextran sulfate sodium (DSS)-induced colitis, oral ABC-301 attenuated colon shortening and reduced colonic inflammatory myeloid populations and tissue inflammatory biomarkers relative to untreated DSS controls. Following oral administration, iodine-125-associated radioactivity was predominantly detected in gastrointestinal compartments. In seven patient-derived anti-Adalimumab antibody preparations, ABC-301 showed reduced functional susceptibility to inhibition compared with Adalimumab. These findings provide a preclinical proof of concept for IgG-to-sIgA reformatting.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.16.766909
Primary Topic
Monoclonal and Polyclonal Antibodies Research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

From Adalimumab to orally administered secretory IgA: preclinical characterization of ABC-301

Mylène Brousse, Olivier Favre‐Bulle, Armelle Cuvillier, Béatrice Lejeune et al.
1 links
bioRxiv (Cold Spring Harbor Laboratory)
Monoclonal and Polyclonal Antibodies Research
preprint

From Adalimumab to orally administered secretory IgA: preclinical characterization of ABC-301

Mylène Brousse, Olivier Favre‐Bulle, Armelle Cuvillier, Béatrice Lejeune, Amelie Pintat, Jean-Marc Herbert
preprint en

Abstract

Reformatting therapeutic immunoglobulin G (IgG) antibodies into secretory immunoglobulin A (sIgA) may provide an alternative architecture for mucosal drug delivery. We characterized ABC-301, a recombinant human sIgA1 incorporating the antigen-binding regions of Adalimumab, and evaluated its human tumor necrosis factor alpha (TNFα) neutralization, oral activity in experimental colitis, tissue biodistribution, and susceptibility to patient-derived anti-Adalimumab antibodies. ABC-301 retained human TNFα binding and functional neutralization in vitro. Its whole-molecule molar neutralization IC50 was approximately 3.3-fold lower than that of Adalimumab, a difference of approximately 1.6-fold after normalization to theoretical binding-site number. In dextran sulfate sodium (DSS)-induced colitis, oral ABC-301 attenuated colon shortening and reduced colonic inflammatory myeloid populations and tissue inflammatory biomarkers relative to untreated DSS controls. Following oral administration, iodine-125-associated radioactivity was predominantly detected in gastrointestinal compartments. In seven patient-derived anti-Adalimumab antibody preparations, ABC-301 showed reduced functional susceptibility to inhibition compared with Adalimumab. These findings provide a preclinical proof of concept for IgG-to-sIgA reformatting.

bioRxiv (Cold Spring Harbor Laboratory)
United Parcel Service (United States) (US), Institut Marcel Mauss (FR), Hexcel (United States) (US)
Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique
Good health and well-being
Monoclonal and Polyclonal Antibodies Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon